当前位置: X-MOL 学术Bioorg. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor
Bioorganic & Medicinal Chemistry ( IF 3.3 ) Pub Date : 2021-01-22 , DOI: 10.1016/j.bmc.2021.116033
Kazuo Shimizu 1 , Hideki Fujikura 2 , Nobuhiko Fushimi 2 , Toshihiro Nishimura 2 , Kazuya Tatani 2 , Kenji Katsuno 2 , Yoshikazu Fujimori 2 , Shinjiro Watanabe 2 , Masahiro Hiratochi 2 , Takeshi Nakabayashi 2 , Noboru Kamada 2 , Koichi Arakawa 2 , Hidemasa Hikawa 3 , Isao Azumaya 3 , Masayuki Isaji 2
Affiliation  

We optimized the structure of an active metabolite (1) of WAY-123783, which was obtained from mouse urine after oral administration, to improve selectivity for SGLT2 and oral bioavailability. O-glucoside derivative 24 (remogliflozin etabonate) was subsequently identified as a potent, highly selective, and orally available SGLT2 inhibitor.



中文翻译:

发现 remogliflozin etabonate:一种有效且高度选择性的 SGLT2 抑制剂

我们优化了口服给药后从小鼠尿液中获得的 WAY-123783活性代谢物(1)的结构,以提高对 SGLT2 的选择性和口服生物利用度。O-葡萄糖苷衍生物24(remogliflozin etabonate)随后被鉴定为一种有效的、高选择性的、可口服的 SGLT2 抑制剂。

更新日期:2021-02-11
down
wechat
bug